Stents, scaffolds and DCB

Latest Stents, scaffolds and DCB content in interventional cardiology - research, practice, and education

Since 1986, when the first cardiovascular stent was implanted, the development of drug-eluting stents (DES) and the recent introduction of bioresorbable scaffolds have revolutionised interventional cardiology. Keep up-to-date with the latest research; evolving tools, devices and techniques; the role of adjunctive pharmacotherapy; advances in imaging techniques as well as the use of invasive imaging and functional assessment. Find out more…

Filtered By
Stents, scaffolds and DCB

505 results

The ARC consensus on DCB - evidence-based DCB technology

15 May 2024 – From EuroPCR 2024

In this replay, discover why DCBs are essential in treating de novo CAD, the importance of optimal lesion preparation for long-term success, and how future trials will focus on treatment strategies rather than device comparisons, highlighting the need for further research.

Evidence-based on DCB technology that have dictated the ARC consensus on DCB

Make your life easier with imaging during primary PCI for acute coronary syndrome

15 May 2024 – From EuroPCR 2024

This session features selected EuroPCR 2024 Clinical Case submissions highlighting the use of imaging modalities, such as optical coherence tomography (OCT) and intravascular ultrasound (IVUS), during primary percutaneous coronary interventions (PCI) for acute coronary syndrome. Experts will present and discuss challenging cases, demonstrating how the integration...

Make your life easier with imaging during primary PCI for acute coronary syndrome

Stentless PCI

15 May 2024 – From EuroPCR 2024

This session explores various stentless percutaneous coronary intervention (PCI) strategies, including drug-coated balloon (DCB)-only PCI for chronic total occlusions and de-novo coronary lesions, as well as the use of magnesium resorbable scaffolds. Attendees will learn about the rationale, techniques, and outcomes of these "leave nothing behind"...

Stentless PCI

Second generation biolimus drug-coated balloon in clinical practice

15 May 2024 – From EuroPCR 2024

Discover the potential applications of the new biolimus-coated balloon in treating de novo large vessel lesions, explore its effectiveness in addressing ISR based on findings from the BIO ASCEND ISR study, and uncover insights into the safety and feasibility of BA9 DCB in treating small vessel,...

Second generation biolimus drug-coated balloon in clinical practice

Go beyond metal: exploring drug-eluting balloon technology in de-novo coronary lesions

15 May 2024 – From EuroPCR 2024

Through the study of two cases, this session examines the need for stenting bifurcation lesions and the role of DEB technology in avoiding stent-related complications in long diffuse disease. It emphasizes the benefits of SELUTION SLR balloons for de novo lesions, discussing how sustained limus release...

Go beyond metal: exploring drug-eluting balloon technology in de-novo coronary lesions

Tools and technologies guiding decision making in bifurcation PCI

15 May 2024 – From EuroPCR 2024

In this session, discover that provisional stenting in routine non-LM bifurcation using Resolute Onyx DES yields good mid-term outcomes without side branch intervention, provided the stent is sized to the distal reference and the side branch remains patent after a systematic POT. Learn how bifurcation stenting...

Tools and technologies guiding decision making in bifurcation PCI

How do I confidently expand my DCB practice?

15 May 2024 – From EuroPCR 2024

This session offers insights on identifying appropriate lesions for DCB treatment, understanding the essential concepts for achieving optimal immediate results with DCB PCI, and exploring the long-term angiographic and clinical outcomes. The session emphasizes the importance of lesion preparation, notes that there are no contraindications for...

How do I confidently expand my DCB practice?

Artificial intelligence-powered quantification of coronary physiology and vulnerable plaque: opportunities for novel treatment options

15 May 2024 – From EuroPCR 2024

In this session, uncover new data on Murray-law based quantitative flow ratio (muFR) assessment, providing a comprehensive understanding of PCI outcomes from a single angiographic view, explore the innovative application of artificial intelligence in identifying vulnerable plaque and assessing hemodynamic stenosis significance through the analysis of...

Artificial intelligence-powered quantification of coronary physiology and vulnerable plaque: opportunities for novel treatment options

Complex PCI in ACS patient with high bleeding risk: optimise the strategy

15 May 2024 – From EuroPCR 2024

Watch this session for insights into managing acute coronary syndrome patients with multivessel disease, updates on treatment approaches, comparing FULL RESVAC with previous trials like COMPLETE or FIRE, for example, and information on ongoing trials such as FRAMI-AMI 2 and 3. Explore the LIVE case presentation...

Complex PCI in ACS patient with high bleeding risk: optimise the strategy

PCI: complex procedures

14 May 2024 – From EuroPCR 2024

This session explores a series of complex PCI cases, including the management of left main stent restenosis after the chimney technique, aortic root dissection during right coronary artery PCI, treatment of very old saphenous graft disease, complex in-stent restenosis, and the management of persistent coronary fistula....

PCI: complex procedures